VEGF inhibitors make blood

Nature Medicine

Volumn 12, Issue 7, 2006, Pages 732-734

  Fischer, Christian ^a   Carmeliet, Peter ^a   Conway, Edward M ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BONE MORPHOGENETIC PROTEIN; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PLACENTAL GROWTH FACTOR; SCATTER FACTOR; SEMAXANIB; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BLOOD CELL; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CYTOTOXICITY; DISEASE COURSE; DRUG EFFICACY; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEEDBACK SYSTEM; HEMANGIOBLASTOMA; HEMATOPOIETIC CELL; HUMAN; HYPERTENSION; LIVER PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; THROMBOSIS; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; VON HIPPEL LINDAU DISEASE;

ANGIOGENESIS INHIBITORS; ANIMALS; ERYTHROPOIESIS; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTORS; HUMANS; MODELS, ANIMAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745875613     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0706-732     Document Type: Short Survey

References (16)

1. Carmeliet, P. Nature 438, 932-936 (2005).
2. Tam, B.Y.Y. et al. Nat. Med. 12, 793-800 (2006).
3. Willett, C.G. et al. J. Clin. Oncol. 23, 8136-8139 (2005).
4. Casanovas, O., Hicklin, D.J., Bergers, G. & Hanahan, D. Cancer Cell 8, 299-309 (2005).
5. Heeschen, C. et al. Blood 102, 1340-1346 (2003).
6. Kertesz, N., Wu, J., Chen, T.H., Sucov, H.M. & Wu, H. Dev. Biol. 276, 101-110 (2004).
7. Kamba, T. et al. Am. J. Physiol. Heart Circ. Physiol. 290, H560-H576 (2006).
8. LeCouter, J. et al. Science 299, 890-893 (2003).
9. Cleaver, O. & Melton, D.A. Nat. Med. 9, 661-668 (2003).
10. Hardee, M.E., Arcasoy, M.O., Blackwell, K.L., Kirkpatrick, J.P. & Dewhirst, M.W. Clin. Cancer Res. 12, 332-339 (2006).
11. Batra, S., Perelman, N., Luck, L.R., Shimada, H. & Malik, P. Lab Invest. 83, 1477-1487 (2003).
12. Yasuda, Y. et al. Br. J. Cancer 84, 836-843 (2001).
13. Leyland-Jones, B. et al. J. Clin. Oncol. 23, 5960-5972 (2005).
14. Stuben, G. et al. J. Cancer Res. Clin. Oncol. 127, 346-350 (2001).
15. Bohlius, J. et al. J. Natl. Cancer Inst. 98, 708-714 (2006).
16. Ribatti, D., Vacca, A., Roccaro, A.M., Crivellato, E. & Presta, M. Eur. J. Clin. Invest. 33, 891-896 (2003).